Sorry, the video which you have requested is not yet processed.

Filter By:
04:28
Diagnosed just three years ago with a myeloproliferat​ive neoplasm (MPN) , Carolyn immediately became proactive in communicating with her healthcare team and was connected with Dr. Brady Stein. She sees Dr. Stein regularly and stresses the importance of having a good relationship with your physician....
by:patientpower | 23 views
04:28
Diagnosed just three years ago with a myeloproliferat​ive neoplasm (MPN) , Carolyn immediately became proactive in communicating with her healthcare team and was connected with Dr. Brady Stein. She sees Dr. Stein regularly and stresses the importance of having a good relationship with your physician....
by:patientpower | 17 views
10:16
T cells, B cells, natural killer cells—all funny names, but how are they are significant when understanding your lab test results? Find out from University of Massachusetts Dartmouth laboratory scientist Dr. Susan Leclair as she takes us on a step-by-step exploration of lymphocyte function and th...
by:patientpower | 15 views
01:49
As part of our Ask the Expert series, Dr. Olatoyosi Odenike of the University of Chicago Medical Center responds to a question from our community discussing what causes itching related to myeloproliferat​ive neoplasms (MPNs). Dr. Odenike describes what researchers have learned about why itching occur...
by:patientpower | 36 views
04:30
http://cance... For ALK+ lung cancer patients, brain metastases are a common concern. Dr. Robert Doebele discusses the options available to treat brain mets as well as drugs that may break through the blood/brain barrier. February 2014 GRACEcast 271 Lung
by:cancergrace | 48 views
06:25
MPN expert Dr. Brady Stein explains recent research that highlights the positive impact of JAK inhibitors on spleen size, symptoms and survival and the potential for deeper effects, including evidence of bone marrow stability and improvement over time. Dr. Stein explores the next wave of promising JAK inhibitors and how logical and novel combinatio...
by:patientpower | 69 views
06:31
Dr. Ruben Mesa, dedicated MPN researcher and deputy director of the Mayo Clinic Cancer Center, explores the evolving MPN treatment landscape and his hope for "multiple&​quot; new options in the near future. Dr. Mesa discusses study results evaluating the long-term experience with JAK inhibitors and their impact on symptoms, quality of life an...
by:patientpower | 69 views
03:03
During a roundtable discussion from the 2014 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Dr. Srdan Verstovsek, Dr. Ross Levine and Dr. Olatoyosi Odenike discussed how JAK inhibitors may factor in as a treatment for some MPN patients prior to transplant. The experts stress...
by:patientpower | 164 views
08:17
During a roundtable discussion, led by Dr. Srdan Verstovsek from MD Anderson Cancer Center, at the 2014 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Dr. Ross Levine from Memorial Sloan Kettering Cancer Center and Dr. Olatoyosi Odenike from University of Chicago Medical Cen...
by:patientpower | 50 views
02:45
As part of a roundtable discussion from the 2014 American Society of Clinical Oncology (ASCO) meeting, Dr. Ross Levine from Memorial Sloan Kettering Cancer Center describes exciting developments with genetics in MPN treatment. He details how the discovery of various gene mutations are affecting trea...
by:patientpower | 178 views
Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)